Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention

This publication has 29 references indexed in Scilit:

• Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents
  Circulation, 2012
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials
  Circulation, 2011
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
  The Lancet, 2011
• Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment
  New England Journal of Medicine, 2010
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
  The Lancet, 2009
• Cytochrome P-450 Polymorphisms and Response to Clopidogrel
  New England Journal of Medicine, 2009
• Clinical End Points in Coronary Stent Trials
  Circulation, 2007
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  JACC, 1988